Gregory Lanza

Professor of Medicine, James R Hornsby Family Professor of Biomedical Sciences

    • Source: Scopus
    1979 …2021

    Research activity per year

    If you made any changes in Pure these will be visible here soon.

    Personal profile

    Research interests

    Dr. Lanza is a Director of CTRAIN, which is installing a clinical MRI as part of a WU-United Imaging in Healthcare collaboration. The program will be IAC accredited and heavily focused on cardio-oncology. The primary research will be to utilize MRI to assess cardiac toxicity imparted from cancer therapeutics, e.g. TKI, anthracyclines, PD-1, and secondary disease manifestations, e.g., amyloid. in myeloma. The program seeks to simplify MR acquisition and reporting techniques and to project patient therapeutic outcomes using Artificial Intelligence. AI will be used to assist in hybridizing myocardial tissue characterization data, reflective of inflammation, fibrosis, and inflitrate, with demographic and blood based clinical pathology indicators.

    In addition, Dr. Lanza has coinvented numerous nanoparticle platforms for molecular imaging with MRI, ultrasound, CT, optical, and photoacoustics. In addition, he has developed nanoparticle platforms and compatible prodrugs to address a variety of unmet medical needs in cardiovascular disease, cancer, and arthritis.

    Areas of Clinical Interest

    Heart disease, molecular imaging, in vivo molecular imaging, site targeted ultrasound; supervising and interpreting diagnostic tests, such as echocardiograms, stress echocardiograms, treadmill stress test, holter, event and loop monitors


    Dive into the research topics where Gregory Lanza is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles


    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or